Global Phenylketonuria Treatment

Phenylketonuria Treatment Comprehensive Study by Type (Drugs (Kuvan, Pegvaliase and Others), Dietary Supplement), Application (Hospital Pharmacies, Drug Stores, Online Pharmacies, Pediatric Clinics), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) Players and Region - Global Market Outlook to 2026

Phenylketonuria Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Phenylketonuria Treatment Market?

Phenylketonuria (PKU) is a rare inherited disorder that increases the levels of a substance called phenylalanine, a building block of proteins (an amino acid), in the blood. This disorder caused by a defect in the PAH gene that helps to create phenylalanine hydroxylase, the enzyme responsible for breaking down phenylalanine. A complete cure for Phenylketonuria is not available but patients can relieve their symptoms and prevent complications by following a special diet and by taking medications. The factors such as Increasing Prevalence of Phenylketonuria among People and Increased Awareness about Phenylketonuria Treatment Options are the key drivers for the global Phenylketonuria Treatment market.

The market study is being classified by Type (Drugs (Kuvan, Pegvaliase and Others) and Dietary Supplement), by Application (Hospital Pharmacies, Drug Stores, Online Pharmacies and Pediatric Clinics) and major geographies with country level break-up.

BioMarin Pharmaceutical Inc. (United States), Dimension Therapeutics, Inc. (United States), Synthetic Biologics, Inc. (United States), Codexis, Inc. (United States), SOM Innovation Biotech (Spain), Daiichi Sankyo Company (Japan) and Erytech Pharma SA (France) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Phenylketonuria Treatment market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Phenylketonuria Treatment market by Type, Application and Region.

On the basis of geography, the market of Phenylketonuria Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Prevalence of Phenylketonuria among People
  • Increased Awareness about Phenylketonuria Treatment Options

Market Trend
  • Increased Research and Development Activities for Novel Drugs

Restraints
  • Lack of Complete Cure Treatment for Phenylketonuria

Opportunities
  • Growth in the Healthcare Industry Worldwide
  • Increased Government Funding

Challenges
  • Stringent Government Rules and Regulations





Key Target Audience
Phenylketonuria Treatment Providers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Drugs (Kuvan, Pegvaliase and Others)
  • Dietary Supplement
By Application
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Pediatric Clinics
By Route of Administration
  • Oral
  • Parenteral

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Phenylketonuria among People
      • 3.2.2. Increased Awareness about Phenylketonuria Treatment Options
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Research and Development Activities for Novel Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Phenylketonuria Treatment, by Type, Application, Route of Administration, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Phenylketonuria Treatment (Value)
      • 5.2.1. Global Phenylketonuria Treatment by: Type (Value)
        • 5.2.1.1. Drugs (Kuvan, Pegvaliase and Others)
        • 5.2.1.2. Dietary Supplement
      • 5.2.2. Global Phenylketonuria Treatment by: Application (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Drug Stores
        • 5.2.2.3. Online Pharmacies
        • 5.2.2.4. Pediatric Clinics
      • 5.2.3. Global Phenylketonuria Treatment by: Route of Administration (Value)
        • 5.2.3.1. Oral
        • 5.2.3.2. Parenteral
      • 5.2.4. Global Phenylketonuria Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Online
        • 5.2.4.4. Others
      • 5.2.5. Global Phenylketonuria Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Phenylketonuria Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioMarin Pharmaceutical Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Dimension Therapeutics, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Synthetic Biologics, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Codexis, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. SOM Innovation Biotech (Spain)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Daiichi Sankyo Company (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Erytech Pharma SA (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Phenylketonuria Treatment Sale, by Type, Application, Route of Administration, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Phenylketonuria Treatment (Value)
      • 7.2.1. Global Phenylketonuria Treatment by: Type (Value)
        • 7.2.1.1. Drugs (Kuvan, Pegvaliase and Others)
        • 7.2.1.2. Dietary Supplement
      • 7.2.2. Global Phenylketonuria Treatment by: Application (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Drug Stores
        • 7.2.2.3. Online Pharmacies
        • 7.2.2.4. Pediatric Clinics
      • 7.2.3. Global Phenylketonuria Treatment by: Route of Administration (Value)
        • 7.2.3.1. Oral
        • 7.2.3.2. Parenteral
      • 7.2.4. Global Phenylketonuria Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Online
        • 7.2.4.4. Others
      • 7.2.5. Global Phenylketonuria Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Phenylketonuria Treatment: by Type(USD Million)
  • Table 2. Phenylketonuria Treatment Drugs (Kuvan, Pegvaliase and Others) , by Region USD Million (2015-2020)
  • Table 3. Phenylketonuria Treatment Dietary Supplement , by Region USD Million (2015-2020)
  • Table 4. Phenylketonuria Treatment: by Application(USD Million)
  • Table 5. Phenylketonuria Treatment Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 6. Phenylketonuria Treatment Drug Stores , by Region USD Million (2015-2020)
  • Table 7. Phenylketonuria Treatment Online Pharmacies , by Region USD Million (2015-2020)
  • Table 8. Phenylketonuria Treatment Pediatric Clinics , by Region USD Million (2015-2020)
  • Table 9. Phenylketonuria Treatment: by Route of Administration(USD Million)
  • Table 10. Phenylketonuria Treatment Oral , by Region USD Million (2015-2020)
  • Table 11. Phenylketonuria Treatment Parenteral , by Region USD Million (2015-2020)
  • Table 12. Phenylketonuria Treatment: by Distribution Channel(USD Million)
  • Table 13. Phenylketonuria Treatment Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Phenylketonuria Treatment Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 15. Phenylketonuria Treatment Online , by Region USD Million (2015-2020)
  • Table 16. Phenylketonuria Treatment Others , by Region USD Million (2015-2020)
  • Table 17. South America Phenylketonuria Treatment, by Country USD Million (2015-2020)
  • Table 18. South America Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 19. South America Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 20. South America Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 21. South America Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 22. Brazil Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 23. Brazil Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 24. Brazil Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 25. Brazil Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 26. Argentina Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 27. Argentina Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 28. Argentina Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 29. Argentina Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 30. Rest of South America Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 33. Rest of South America Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 34. Asia Pacific Phenylketonuria Treatment, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 38. Asia Pacific Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 39. China Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 40. China Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 41. China Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 42. China Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 43. Japan Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 44. Japan Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 45. Japan Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 46. Japan Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 47. India Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 48. India Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 49. India Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 50. India Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 51. South Korea Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 52. South Korea Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 53. South Korea Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 54. South Korea Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 55. Taiwan Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 56. Taiwan Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 57. Taiwan Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 58. Taiwan Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 59. Australia Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 60. Australia Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 61. Australia Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 62. Australia Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 67. Europe Phenylketonuria Treatment, by Country USD Million (2015-2020)
  • Table 68. Europe Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 69. Europe Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 70. Europe Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 71. Europe Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 72. Germany Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 73. Germany Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 74. Germany Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 75. Germany Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 76. France Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 77. France Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 78. France Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 79. France Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 80. Italy Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 81. Italy Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 82. Italy Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 83. Italy Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 84. United Kingdom Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 87. United Kingdom Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 88. Netherlands Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 89. Netherlands Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 90. Netherlands Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 91. Netherlands Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 92. Rest of Europe Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 95. Rest of Europe Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 96. MEA Phenylketonuria Treatment, by Country USD Million (2015-2020)
  • Table 97. MEA Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 98. MEA Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 99. MEA Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 100. MEA Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 101. Middle East Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 102. Middle East Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 103. Middle East Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 104. Middle East Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 105. Africa Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 106. Africa Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 107. Africa Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 108. Africa Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 109. North America Phenylketonuria Treatment, by Country USD Million (2015-2020)
  • Table 110. North America Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 111. North America Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 112. North America Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 113. North America Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 114. United States Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 115. United States Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 116. United States Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 117. United States Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 118. Canada Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 119. Canada Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 120. Canada Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 121. Canada Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 122. Mexico Phenylketonuria Treatment, by Type USD Million (2015-2020)
  • Table 123. Mexico Phenylketonuria Treatment, by Application USD Million (2015-2020)
  • Table 124. Mexico Phenylketonuria Treatment, by Route of Administration USD Million (2015-2020)
  • Table 125. Mexico Phenylketonuria Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Phenylketonuria Treatment: by Type(USD Million)
  • Table 134. Phenylketonuria Treatment Drugs (Kuvan, Pegvaliase and Others) , by Region USD Million (2021-2026)
  • Table 135. Phenylketonuria Treatment Dietary Supplement , by Region USD Million (2021-2026)
  • Table 136. Phenylketonuria Treatment: by Application(USD Million)
  • Table 137. Phenylketonuria Treatment Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 138. Phenylketonuria Treatment Drug Stores , by Region USD Million (2021-2026)
  • Table 139. Phenylketonuria Treatment Online Pharmacies , by Region USD Million (2021-2026)
  • Table 140. Phenylketonuria Treatment Pediatric Clinics , by Region USD Million (2021-2026)
  • Table 141. Phenylketonuria Treatment: by Route of Administration(USD Million)
  • Table 142. Phenylketonuria Treatment Oral , by Region USD Million (2021-2026)
  • Table 143. Phenylketonuria Treatment Parenteral , by Region USD Million (2021-2026)
  • Table 144. Phenylketonuria Treatment: by Distribution Channel(USD Million)
  • Table 145. Phenylketonuria Treatment Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 146. Phenylketonuria Treatment Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 147. Phenylketonuria Treatment Online , by Region USD Million (2021-2026)
  • Table 148. Phenylketonuria Treatment Others , by Region USD Million (2021-2026)
  • Table 149. South America Phenylketonuria Treatment, by Country USD Million (2021-2026)
  • Table 150. South America Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 151. South America Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 152. South America Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 153. South America Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 154. Brazil Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 155. Brazil Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 156. Brazil Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 157. Brazil Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 158. Argentina Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 159. Argentina Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 160. Argentina Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 161. Argentina Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 162. Rest of South America Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 163. Rest of South America Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 164. Rest of South America Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 165. Rest of South America Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 166. Asia Pacific Phenylketonuria Treatment, by Country USD Million (2021-2026)
  • Table 167. Asia Pacific Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 168. Asia Pacific Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 169. Asia Pacific Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 170. Asia Pacific Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 171. China Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 172. China Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 173. China Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 174. China Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 175. Japan Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 176. Japan Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 177. Japan Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 178. Japan Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 179. India Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 180. India Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 181. India Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 182. India Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 183. South Korea Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 184. South Korea Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 185. South Korea Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 186. South Korea Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 187. Taiwan Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 188. Taiwan Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 189. Taiwan Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 190. Taiwan Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 191. Australia Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 192. Australia Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 193. Australia Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 194. Australia Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 195. Rest of Asia-Pacific Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 196. Rest of Asia-Pacific Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 197. Rest of Asia-Pacific Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 198. Rest of Asia-Pacific Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 199. Europe Phenylketonuria Treatment, by Country USD Million (2021-2026)
  • Table 200. Europe Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 201. Europe Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 202. Europe Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 203. Europe Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 204. Germany Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 205. Germany Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 206. Germany Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 207. Germany Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 208. France Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 209. France Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 210. France Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 211. France Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 212. Italy Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 213. Italy Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 214. Italy Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 215. Italy Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 216. United Kingdom Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 217. United Kingdom Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 218. United Kingdom Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 219. United Kingdom Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 220. Netherlands Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 221. Netherlands Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 222. Netherlands Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 223. Netherlands Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 224. Rest of Europe Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 225. Rest of Europe Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 226. Rest of Europe Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 227. Rest of Europe Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 228. MEA Phenylketonuria Treatment, by Country USD Million (2021-2026)
  • Table 229. MEA Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 230. MEA Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 231. MEA Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 232. MEA Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 233. Middle East Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 234. Middle East Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 235. Middle East Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 236. Middle East Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 237. Africa Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 238. Africa Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 239. Africa Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 240. Africa Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 241. North America Phenylketonuria Treatment, by Country USD Million (2021-2026)
  • Table 242. North America Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 243. North America Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 244. North America Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 245. North America Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 246. United States Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 247. United States Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 248. United States Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 249. United States Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 250. Canada Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 251. Canada Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 252. Canada Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 253. Canada Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 254. Mexico Phenylketonuria Treatment, by Type USD Million (2021-2026)
  • Table 255. Mexico Phenylketonuria Treatment, by Application USD Million (2021-2026)
  • Table 256. Mexico Phenylketonuria Treatment, by Route of Administration USD Million (2021-2026)
  • Table 257. Mexico Phenylketonuria Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 258. Research Programs/Design for This Report
  • Table 259. Key Data Information from Secondary Sources
  • Table 260. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Phenylketonuria Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Phenylketonuria Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Phenylketonuria Treatment: by Route of Administration USD Million (2015-2020)
  • Figure 7. Global Phenylketonuria Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 8. South America Phenylketonuria Treatment Share (%), by Country
  • Figure 9. Asia Pacific Phenylketonuria Treatment Share (%), by Country
  • Figure 10. Europe Phenylketonuria Treatment Share (%), by Country
  • Figure 11. MEA Phenylketonuria Treatment Share (%), by Country
  • Figure 12. North America Phenylketonuria Treatment Share (%), by Country
  • Figure 13. Global Phenylketonuria Treatment share by Players 2020 (%)
  • Figure 14. Global Phenylketonuria Treatment share by Players (Top 3) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. BioMarin Pharmaceutical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. BioMarin Pharmaceutical Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Dimension Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Dimension Therapeutics, Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Synthetic Biologics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Synthetic Biologics, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Codexis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Codexis, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. SOM Innovation Biotech (Spain) Revenue, Net Income and Gross profit
  • Figure 25. SOM Innovation Biotech (Spain) Revenue: by Geography 2020
  • Figure 26. Daiichi Sankyo Company (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Daiichi Sankyo Company (Japan) Revenue: by Geography 2020
  • Figure 28. Erytech Pharma SA (France) Revenue, Net Income and Gross profit
  • Figure 29. Erytech Pharma SA (France) Revenue: by Geography 2020
  • Figure 30. Global Phenylketonuria Treatment: by Type USD Million (2021-2026)
  • Figure 31. Global Phenylketonuria Treatment: by Application USD Million (2021-2026)
  • Figure 32. Global Phenylketonuria Treatment: by Route of Administration USD Million (2021-2026)
  • Figure 33. Global Phenylketonuria Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 34. South America Phenylketonuria Treatment Share (%), by Country
  • Figure 35. Asia Pacific Phenylketonuria Treatment Share (%), by Country
  • Figure 36. Europe Phenylketonuria Treatment Share (%), by Country
  • Figure 37. MEA Phenylketonuria Treatment Share (%), by Country
  • Figure 38. North America Phenylketonuria Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BioMarin Pharmaceutical Inc. (United States)
  • Dimension Therapeutics, Inc. (United States)
  • Synthetic Biologics, Inc. (United States)
  • Codexis, Inc. (United States)
  • SOM Innovation Biotech (Spain)
  • Daiichi Sankyo Company (Japan)
  • Erytech Pharma SA (France)
Select User Access Type

Key Highlights of Report


Apr 2021 244 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Phenylketonuria Treatment Quantitative research analysis
Global Phenylketonuria Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Prevalence of Phenylketonuria among People " is seen as one of major growth factors of Phenylketonuria Treatment Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Phenylketonuria Treatment Report?

Have a Query? Click Here

Other Related Reports

Nerve Repair and Regeneration Comprehensive Study by Type (Neurostimulation Devices, Neuromodulation Devices (Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cor...
$ 3750
mRNA Vaccines & Therapeutics Comprehensive Study by Type (Standardization of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, In...
$ 3750
Antibody Services Comprehensive Study by Type (Polyclonal antibody, Monoclonal antibody, Murine, Chimeric, Humanize, Other), Application (Gastroenterology, Rheumatology, Infection, Cardiology, Hemato...
$ 3650
Liver Disease Treatment Comprehensive Study by Application (Hospital, Clinic, Others), Disease Type (Hepatitis, Autoimmune diseases, Liver tumor, Chronic liver disease, Fatty liver disease.), Treatme...
$ 3650
Cancer Pain Therapeutics Comprehensive Study by Type (Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others), Application (Related Immunotherapy, Radiotherapy, Chemotherapy, Hormone Therapy), End Us...
$ 3350
Antinuclear Antibody Test Comprehensive Study by Type (Reagents and Assay Kits, Software and Services, Systems), Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Scler...
$ 3750